Vet Med - Czech, 2014, 59(12):631-636 | DOI: 10.17221/7823-VETMED

Effects of inactivated Parapoxvirus ovis on polymorphonuclear leukocyte function and myeloperoxidase activity in horsesOriginal Paper

S. Ulgen1, C.P. Yaramis2, E. Rayaman3, U. Soyogul Gurer3, M.E. Or1, A.O. Sehirli3
1 Faculty of Veterinary, Istanbul University, Istanbul, Turkey
2 Vocational School of Veterinary Faculty, Istanbul University, Istanbul, Turkey
3 Faculty of Pharmacy, Marmara University, Istanbul, Turkey

Immunomodulatory products have been used for years in veterinary medicine. Inactivated Parapoxvirus ovis (iPPVO) is currently used in equine medicine as an immunomodulator to improve the immune system and as a prophylactic treatment to prevent or treat infectious diseases. This study was designed to determine the effects of iPPVO on polymorphonuclear leukocyte (PMNL) function (phagocytosis and intracellular killing activity) and the myeloperoxidase (MPO) activity of PMNLs in horses. Twenty-four healthy English thoroughbred horses with an average age of 11 years were included in the study. Venous blood samples (10 ml) were taken before (agent-free controls) and after the administration of iPPVO (2 ml i.m. injection on Days 1, 3, and 5). PMNLs (1 × 107 cells/ml) were isolated from venous blood containing EDTA (0.1 g/ml) with Ficoll-Hypaque gradient centrifugation. Cellular phagocytosis and intracellular killing activities were assayed using a modification of Alexander's method before and after treatment with iPPVO. MPO activity was also measured. The administration of iPPVO significantly increased the phagocytic, intracellular killing, and MPO activities of equine PMNLs (P = 0.0058, P = 0.0050, and P = 0.0070, respectively). This study demonstrates a strong correlation between MPO activity and PMNL function. The administration of iPPVO to horses has a supportive effect on their cellular immunity and an immunomodulatory effect against equine viral infections.

Keywords: equine; inactivated Parapoxvirus ovis; phagocytosis; intracellular killing activity; myeloperoxidase

Published: December 31, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ulgen S, Yaramis CP, Rayaman E, Soyogul Gurer U, Or ME, Sehirli AO. Effects of inactivated Parapoxvirus ovis on polymorphonuclear leukocyte function and myeloperoxidase activity in horses. Vet Med - Czech. 2014;59(12):631-636. doi: 10.17221/7823-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adams AA, Horohov DW (2013): The effect of an immunomodulator (Parapoxvirus ovis) on cell-mediated immunity (CMI) in abruptly weaned foals. Veterinary Immunology and Immunopathology 153, 118-122. Go to original source... Go to PubMed...
    2. Alexander JW, Windhorst DB, Good RA (1968): Improved tests for the evolution of neutrophil function in human disease. Journal of Laboratory and Clinical Medicine 72, 136-148. Go to PubMed...
    3. Barbior BM, Cohen HJ (1981): Measurement of neutrophil function: phagocytosis, degranulation, the respiratory burst and bacterial killing. In: Cline MJ (ed.): Methods in Hematology, Leukocyte Function: 1st ed. Churchill Livingstone, New York. 1-38.
    4. Boogaerts MA, Malbrain S, Scheers W, Verwilghen RL (1986): Effects of quinolones on granulocyte function in vitro. Infection 14, 258-262. Go to original source... Go to PubMed...
    5. Castrucci G, Osburn BI, Frigeri F, Ferrari M, Salvatori DDM, Barreca F (2000): The use of immunomodulators in the control of infectious bovine rhinotracheitis. Comparative Immunology, Microbiology and Infectious Diseases 23, 163-173. Go to original source... Go to PubMed...
    6. Glitz F (2003): Effects and indications regarding use of immunmodulator (Baypamun®), Bayer Pferdeheilkunde 19,170-176. Go to original source...
    7. Hartert M, Bourgeois E, Grulke S, Dupont G, Caudron I, Deby C, Lamy M, Didier S (1998): Purification of myeloperoxidase from equine polymorphonuclear leucocytes. Canadian Journal of Veterinary Research 62, 127-132.
    8. Hillegas LM, Griswold DE, Brickson B, AlbrightsonWinslow C (1990): Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacological Methods 24, 285-295. Go to original source... Go to PubMed...
    9. Horohov DW, Breathnach CC, Sturgill TL, Rashid C, Stiltner JL, D. Strong D, N. Nieman N, Holland RE (2008): In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis. Equine Veterinary Journal 40, 468-472. Go to original source... Go to PubMed...
    10. Kart A, Uzlu E, Karapehlivan M, Ogun M, Merhan O (2010): Effect of immunomodulator zylexis on blood glutathione, malondialdehyde, nitric oxide, total and lipid bound sialic acids levels in calves (in Turkish). Ankara Universitesi Veteriner Bilimleri Dergisi 5, 43-48.
    11. Kettle AJ, Winterbourn CC (1991): Mechanism on inhibition of myeloperoxidase by anti-inflammatory drugs. Biochemical Pharmacology 41, 1485-1492. Go to original source... Go to PubMed...
    12. Klebanoff SJ (2005): Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 77, 598-625. Go to original source... Go to PubMed...
    13. Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B (2005): Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-Superoxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators of Inflammation 14, 390-394. Go to original source... Go to PubMed...
    14. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951): Protein measurement with the Folin phenyl reagent. Journal of Biochemistry 193, 265-275. Go to original source...
    15. Malle E, Furtmuller PG, Sattler W, Obinger C (2007): Myeloperoxidase: a target for new drug development? British Journal of Pharmacology 152, 838-854. Go to original source... Go to PubMed...
    16. Paillot RA (2013): Systematic review of the immunemodulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse. Veterinary Immunology and Immunopathology 153, 1-9. Go to original source... Go to PubMed...
    17. Ponthier J, Desvals M, Rebière G, Spalart M, Palmer E, Serteyn D, Deleuze S (2012): Myeloperoxidase (MPO) is a pro-oxidant enzyme contained in and released by ex vivo exposure to Rhodococcus equi. Veterinary Immunology and Immunopathology 138, 198-205.
    18. Said A, Damiani A, Ma G, Kalthoff D, Beer M, Osterrieder N (2011): An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1.Veterinary Microbiology 154,113-123. Go to original source... Go to PubMed...
    19. Schutze N, Raue R, Buttner M, Kohler G, McInnes CJ, Alber G (2010): Specific antibodies induced by inactivated Parapoxvirus ovis potently enhance oxidative burst in canine blood polymorphonuclear leukocytes and monocytes. Veterinary Microbiology 140, 81-91. Go to original source... Go to PubMed...
    20. Schutze N, Raue R, Buttner M, Alber G (2009): Inactivated parapoxvirus ovis activates canine blood phagocytes and T lymphocytes. Veterinary Microbiology 137, 260-267. Go to original source... Go to PubMed...
    21. Senoglu M, Kurutas EB, Altun I, Atli Y, Nacitarhan V (2009): Myeloperoxidase activities in polymorphonuclear leukocytes in lumbar disc disease (in Turkish). Journal of Neurological Sciences 26, 292-297.
    22. Weber O, Siegling A, Friebe A, Limmer A, Schlapp T, neutrophils during degranulation or after lysis. Journal Knolle P, Mercer A, Schaller H, Volk HD (2003): Inof Equine Veterinary Science 32, 32-37.
    23. Prokopowicz Z, Marcinkiewicz J, Katz DR, Chain BM (2012): Neutrophil Myeloperoxidase: soldier and statesman. Archivum Immunologiae et Therapiae Experimentalis 60, 43-54. Go to original source... Go to PubMed...
    24. Rush BR, Flaminio MJ (2000): Immunomodulation in horses. Veterinary Clinics of North America: Equine Practice 16, 183-197. Go to original source... Go to PubMed...
    25. Ryan C, Giguere S, Fultz L, Long MT, Crawford PC (2010): Effects of two commercially avaliable immunostimulants on leukocyte function of foals following activated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. Journal of General Virology 84, 1843-1852. Go to original source... Go to PubMed...
    26. Ziebell KL, Steinmann H, Kretzdorn D, Schlapp T, Failing K, Schmeer N (1997): The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses. Zentralblatt fur Veterinarmedizin B 44, 529-536. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content